Tiemann Investment Advisors, LLC Gilead Sciences, Inc. Transaction History

Tiemann Investment Advisors, LLC

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $181,489 - $205,813	2,477 New	2,477 $200,000
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $2,280 - $2,601	30 Added 1.26%	2,412 $185,000
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $4,252 - $4,844	55 Added 2.36%	2,382 $197,000
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $145,018 - $208,196	2,327 New	2,327 $199,000
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $189,803 - $237,844	-3,277 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $212,611 - $241,318	3,277 New	3,277 $238,000
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $205,769 - $224,832	-3,242 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $26,220 - $29,917	437 Added 15.58%	3,242 $210,000
Q1 2021 May 11, 2021	SELL	$60.0 - $68.46 $24,300 - $27,726	-405 Reduced 12.62%	2,805 $324,000
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $4,532 - $5,164	-80 Reduced 2.43%	3,210 $187,000
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $32,602 - $40,992	-525 Reduced 13.76%	3,290 $208,000
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $38,340 - $44,520	530 Added 16.13%	3,815 $294,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $205,739 - $263,522	3,285 New	3,285 $246,000
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $191,972 - $250,509	-3,171 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $226,028 - $250,255	3,171 New	3,171 $245,000
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $192,369 - $224,391	-2,965 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$72.11 - $85.47 $7,211 - $8,547	100 Added 3.49%	2,965 $240,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,865	2,865 $203,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Tiemann Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Tiemann Investment Advisors, LLC with notifications on news.